Page 1 of 4 No. RJH – SET 3/2018 26 February 2018 Subject : Management’s Discussion and Analysis for the fourth Quarter of 2017 and year ended December 31, 2017 To : The President The Stock Exchange
quarter of 2017, company has been investing in equity securities which gains on revaluation of its investments at fair value at ฿ 79 million. However, the Company will continue to adhere security policy to
). The Company will invest 50% of share. Expected to set up the new company registration within 2nd quarter 2019 4. Source of funds: Cash flows from operating activities without any effect on liquidity. 5
. DOD017/2562 May 8, 2019 Re: Management’s Discussion and Analysis (MD&A) of the Consolidated Financial Results for Quarter 1 of 2019 To: The President The Stock Exchange of Thailand DOD Biotech Public
causes and reason for relative financial performance on the items varies more than 20% compared to same quarter of previous year. The company, hereby, explains the Q1-2019 operating performance compared to
13 May 2019 Subject: Management Discussion and Analysis for the Quarter 1 Ending 31 March 2019 Attention: President Stock Exchange of Thailand Please find below the additional information supporting
quarter ending 31 March 2019 amounting to Baht 15.74 million, a decrease of Baht 21.47 million or 57.7%, although net earned premium and fee and commission income increased by Baht 20.4 million or 4.6%, due
. The Company would like to clarify as follows: Following the objectives for the use of capital in IPO prospectus, the Company has a plan to utilize the capital from IPO during 2nd-3rd quarter of 2019. In
54,750,000 cubic meters per year for phase 1A which has commenced operation since the first quarter of 2019. SDWTP is undergoing the phase 1B expansion of another 54,750,000 cubic meters per year, which is
reason for relative financial performance on the items varies more than 20% compared to same quarter of previous year. The company, hereby, explains the Q2-2019 operating performance compared to Q2-2018